
Negative sentiment towards APLS reflected by a jump of 6.82% in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Apellis Pharmaceuticals Inc revealed its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million
In a filing, Apellis Pharmaceuticals Inc revealed its Chief Executive Officer Francois Cedric unloaded Company’s shares for reported $0.4 million